Pharming Group N.V. reported that on June 11, 2025, all proposals were approved at the Annual General Meeting, including the appointment of Dr. Elaine Sullivan to the Board of Directors, while two members did not stand for re-election. Shareholders also reappointed Deloitte as external auditor for 2025 and renewed authorizations for share issuance and buybacks.